Clinical trial

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

NCT06422039

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-05-23

PhasePHASE1

Study timeline

Study start (actual)2024-05-23Date precision: day

Registry last updated2026-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

HRS-7535(D) TabletsDRUG

HRS-7535(C) TabletsDRUG

Sponsors & collaborators

Shandong Suncadia Medicine Co., Ltd.lead sponsor

Mapped research locations

HefeiAnhui, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06422039 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.